Coronavirus Update: FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases

Cheerful interrational couple taking self-portrait together, looking at camera and smiling, posing over yellow background

An FDA panel endorsed the agency’s plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S.